GlassScriptPhysician profile
Christine Law
NPI 1487746392
$1,292.88
in general payments reported to CMS, 2019-2025
12 companies · $323 in 2025
The $323 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.30 · 2020: $91.70 · 2021: $64.09 · 2022: $393 · 2023: $221 · 2024: $136 · 2025: $323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $350.08 | 2020-2025 | Precision 1, Rocklatan, Dailies |
| Bausch & Lomb Americas INC. | $337.79 | 2022-2025 | Infuse, Xiidra, Miebo |
| Eyevance Pharmaceuticals LLC | $258.91 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $99.84 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $74.43 | 2022-2025 | Tyrvaya, Ryzumvi |
| Allergan, INC. | $44.36 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $30.38 | 2019 | |
| Abbvie INC. | $23.35 | 2022 | |
| Harrow Eye, LLC | $22.07 | 2025 | Vevye |
| Kala Pharmaceuticals, INC. | $19.73 | 2021 | |
| Sun Pharmaceutical Industries INC. | $19.07 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $12.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Law listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.